Kelly Lisbakken
About Kelly Lisbakken
Kelly Lisbakken serves as the Managing Director of Life Sciences Investment Banking at Wedbush Pacific Growth, a position she has held since 2004. She studied Molecular Biology at Princeton University.
Work at Wedbush Securities
Kelly Lisbakken has served as the Managing Director of Life Sciences Investment Banking at Wedbush Pacific Growth since 2004. With a tenure of 20 years, Lisbakken has played a significant role in the firm's investment banking operations, focusing on the life sciences sector. This position involves overseeing various financial transactions, advising clients on mergers and acquisitions, and providing strategic insights to enhance business growth within the life sciences industry.
Education and Expertise
Kelly Lisbakken studied at Princeton University, where she earned a degree in Molecular Biology. This educational background provides her with a strong foundation in the scientific principles that underpin the life sciences sector. Her expertise in both finance and molecular biology enables her to effectively bridge the gap between scientific innovation and investment opportunities.
Background
Kelly Lisbakken has built a career in investment banking with a specialization in life sciences. Since joining Wedbush Pacific Growth in 2004, she has accumulated extensive experience in the financial aspects of the life sciences industry. Her background combines scientific knowledge with financial acumen, making her a valuable asset in the field of investment banking.
Achievements
Throughout her career, Kelly Lisbakken has contributed to numerous successful transactions in the life sciences sector. As Managing Director at Wedbush Pacific Growth, she has been instrumental in guiding clients through complex financial processes, enhancing their strategic positioning in the market. Her long-standing role in the firm reflects her commitment to the growth and development of life sciences investment banking.